Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?

STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

Researchers slow neurodegeneration in mice by barring T cells from the brain

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

Trustworthy science journalism is more essential than ever